Our 2025 list of publications include articles produced by our cluster's researchers as well as publications arising from the hard work of our trial units at St Vincent's University Hospital and The Mater Misericordiae University Hospital.
- Aceituno, L., Gravely, A. K., O'Kane, G. M., Vogel, A., & Sapisochin, G. (2025). The use of immunotherapy pre-liver transplant. Journal of hepatology, 82(4), 757–759. https://doi.org/10.1016/j.jhep.2024.11.005
- Beaudry, F. E. G., Li, Z., Borgida, A., Zorigtbaatar, A., Wang, X., Hildebrand, M., Hamza, O., Jang, G. H., Bucur, R., Dodd, A., Wilson, J., Auer, R. C., Saibil, S., Tsang, E. S., Vogel, A., O'Kane, G. M., Gallinger, S., Knox, J. J., Notta, F., Sapisochin, G., … Grant, R. C. (2025). Molecular Tumor Board-Guided Targeted Treatments for Biliary Tract Cancers in a Publicly Funded Healthcare System. Current oncology (Toronto, Ont.), 32(2), 80. https://doi.org/10.3390/curroncol32020080
- Blasco, A., López-Tarruella, S., Urruticoechea, A., Carrasco, E., Spera, G., Martín, M., Bermejo, B., Chap, L., Ruiz-Borrego, M., Crown, J., García-Saenz, J. A., Chan, A., Guerrero-Zotano, Á., Semiglazov, V., Calvo, L., Pienkowski, T., Herranz, J., & Slamon, D. (2025). Intermediate endpoints as surrogates for long-term outcomes in breast cancer adjuvant chemotherapy trials. The oncologist, 30(9), oyaf263. https://doi.org/10.1093/oncolo/oyaf263
- Bredin, P., Galvin, Z., & O'Kane, G. M. (2025). Role of immunotherapy in managing cancers prior to liver transplantation. Current opinion in organ transplantation, 30(1), 3–11. https://doi.org/10.1097/MOT.0000000000001187
- Burke, C., Glynn, T., Jahangir, C., Murphy, C., Buckley, N., Tangney, M., Rahman, A., & Gallagher, W. M. (2025). Exploring the prognostic and predictive potential of bacterial biomarkers in non-gastrointestinal solid tumors. Expert review of molecular diagnostics, 25(4), 117–128. https://doi.org/10.1080/14737159.2025.2465743
- Carroll, G., Sweeney, F. F., Meaney, C., DeFrein, A. M., Higgins, M. J., Keane, M. M., Hayat, A., & Heckmann, P. (2025). Improving cancer care through electronic libraries: A survey of health professionals' experiences with Ireland's systemic anti-cancer therapy regimen library. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 10781552251367356. Advance online publication. https://doi.org/10.1177/10781552251367356
- Choi, W. J., Ivanics, T., Claasen, M., Magyar, C. T. J., Li, Z., Tabrizian, P., Rocha, C., Myers, B., O'Kane, G. M., Reig, M., Ferrer Fàbrega, J., Holgin, V., Parikh, N. D., Pillai, A., Hunold, T. M., Vogel, A., Patel, M. S., Singal, A. G., Tadros, M., Feld, J. J., … Sapisochin, G. (2025). Direct-acting antivirals lower mortality and recurrence in HCV-related hepatocellular carcinoma post liver resection: A multicenter international study. Surgery, 183, 109396. https://doi.org/10.1016/j.surg.2025.109396
- Conduit, C., Inderjeeth, A. J., Allen, R., Martin, A. J., Parulekar, W., Mulroe, E., McJannett, M., Zielinski, R. R., Thomson, A., Tan, T. H., Sandhu, S. K., Reaume, M. N., Pook, D. W., North, S. A., Marx, G. M., Joshua, A., Horvath, L., McDermott, R., Chowdhury, S., Chi, K. N., … ANZUP Cancer Trials Group (2025). Enzalutamide with standard first-line therapy for metastatic hormone-sensitive prostate cancer: a plain language summary of the ENZAMET trial (ANZUP 1304). Future oncology (London, England), 21(6), 627–636. https://doi.org/10.1080/14796694.2024.2440277
- Corcoran, C., Rani, S., Breslin, S., Gogarty, M., Ghobrial, I. M., Crown, J., & O'Driscoll, L. (2025). Correction: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer. Molecular cancer, 24(1), 37. https://doi.org/10.1186/s12943-025-02251-8
- Crown, J., Eustace, A. J., Collins, D. M., Keane, M., Coate, L., Kennedy, J., O'Reilly, S., Kelly, C., O'Connor, M., Martin, M., Murphy, C., Duffy, K., Walshe, J., Gullo, G., Mahgoub, T., Alvarez-Iglesias, A., Parker, I., Donachie, V., Teiserskiene, A., Madden, S. F., … Hennessy, B. T. (2025). TCHL - a phase II neo-adjuvant study assessing TCH (docetaxel, carboplatin and trastuzumab) and TCHL (docetaxel, carboplatin, trastuzumab and lapatinib) in HER-2 positive breast cancer patients: a 5-year follow-up with serum biomarker analysis. Acta oncologica (Stockholm, Sweden), 64, 751–760. https://doi.org/10.2340/1651-226X.2025.43143
- Demeestere, I., Niman, S. M., Partridge, A. H., Diego, D. S., Kammler, R., Ruggeri, M., Colleoni, M., Shimizu, C., Saura, C., Gelmon, K. A., Saetersdal, A. B., Kroep, J. R., Mailliez, A., Amant, F., Ruız-Borrego, M., Lee, J. E., Kataoka, A., Walshe, J. M., Takei, J., Borstnar, S., … International Breast Cancer Study Group and the POSITIVE Trial Collaborators (2025). Corrigendum to "Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial" [The Breast 83 (2025) 104547]. Breast (Edinburgh, Scotland), 84, 104570. Advance online publication. https://doi.org/10.1016/j.breast.2025.104570
- Duffy, M. J., Tang, M., & Crown, J. (2025). MYC as a Target for Cancer Treatment: from Undruggable to Druggable?. Targeted oncology, 20(5), 791–801. https://doi.org/10.1007/s11523-025-01169-x
- Fasching, P. A., Stroyakovskiy, D., Yardley, D. A., Huang, C. S., Crown, J., Bardia, A., Chia, S., Im, S. A., Martin, M., Xu, B., Loi, S., Barrios, C., Untch, M., Moroose, R., Visco, F., Hortobagyi, G. N., Slamon, D. J., Fresco, R., Zarate, J. P., Li, Z., … Hurvitz, S. A. (2025). Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes From the NATALEE Randomized Clinical Trial. JAMA oncology, e253700. Advance online publication. https://doi.org/10.1001/jamaoncol.2025.3700
- García-Saenz, J. A., Spera, G., Pollán, M., Bermejo, B., Ruiz-Borrego, M., Chan, A., Martín, M., Guerrero-Zotano, Á., Calvo, L., Rodríguez-Lescure, Á., Marín, M., Chap, L., Crown, J., Pienkowski, T., Bee, V., Casas, M., Polonio, Ó., Bezares, S., & Slamon, D. (2025). Body mass index as a predictive factor for efficacy of adjuvant taxane-based chemotherapy in early-stage breast cancer patients: A pooled analysis from adjuvant GEICAM Spanish Breast Cancer Group and TRIO Translational Research in Oncology Group studies. International journal of cancer, 157(4), 709–721. https://doi.org/10.1002/ijc.35432
- Geyer, C. E., Jr, Untch, M., Huang, C. S., Mano, M. S., Mamounas, E. P., Wolmark, N., Rastogi, P., Schneeweiss, A., Redondo, A., Fischer, H. H., D'Hondt, V., Conlin, A. K., Guarneri, V., Wapnir, I. L., Jackisch, C., Arce-Salinas, C., Fasching, P. A., DiGiovanna, M. P., Crown, J. P., Wuelfing, P., … KATHERINE Study Group (2025). Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer. The New England journal of medicine, 392(3), 249–257. https://doi.org/10.1056/NEJMoa2406070
- Gillessen, S., Murphy, L., James, N. D., Sachdeva, A., El-Taji, O., Abdel-Aty, H., Adler, A. I., Amos, C., Attard, G., Varughese, M., Gale, J., Brown, S., Srihari, N., Birtle, A. J., Brown, M., Chan, K., Chowdhury, S., Cross, W., Dearnaley, D. P., Din, O., … STAMPEDE investigators (2025). Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol. The Lancet. Oncology, 26(8), 1018–1030. https://doi.org/10.1016/S1470-2045(25)00231-1
- Gillessen, S., Tombal, B., Turco, F., Choudhury, A., Rodriguez-Vida, A., Gallardo, E., Velho, P. I., Nolè, F., Cruz, F., Loriot, Y., McDermott, R., Roumeguere, T., Daugaard, G., Yamamura, R., Bompas, E., Maroto, P., Polo, M. H., da Trindade, K. M., Preto, D. D., Skoneczna, I., … Saad, F. (2025). Decrease in Fracture Rate with Mandatory Bone-protecting Agents in the EORTC 1333/PEACE-3 Trial Comparing Radium-223 Combined with Enzalutamide Versus Enzalutamide Alone: A Safety Analysis. European urology, 87(3), 285–288. https://doi.org/10.1016/j.eururo.2024.11.027
- Gillessen, S., Turco, F., Davis, I. D., Efstathiou, J. A., Fizazi, K., James, N. D., Shore, N., Small, E., Smith, M., Sweeney, C. J., Tombal, B., Zilli, T., Agarwal, N., Antonarakis, E. S., Aparicio, A., Armstrong, A. J., Bastos, D. A., Attard, G., Axcrona, K., Ayadi, M., … Omlin, A. (2025). Management of Patients with Advanced Prostate Cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC). European urology, 87(2), 157–216. https://doi.org/10.1016/j.eururo.2024.09.017
- Goldman, J. W., Bueno, A. M., Dooms, C., Jhaveri, K., de Miguel, M., Piha-Paul, S. A., Unni, N., Zick, A., Mahipal, A., Suga, J. M., Naltet, C., Antoñanzas, M., Crown, J., Bebchuk, J., Eli, L. D., Lowenthal, B. H., & Mahalingam, D. (2025). Neratinib Efficacy in Patients With EGFR Exon 18-Mutant Non-Small-Cell Lung Cancer: Findings From the SUMMIT Basket Trial. Clinical lung cancer, 26(3), 191–200.e1. https://doi.org/10.1016/j.cllc.2024.12.003
- Kelly, S. A., Ronan, K. E., Zameer, M., Brown, J., Johnston, G., Adams, R., Murphy, D., Kelly, D., Darwish, W., McCaffery, J., Coyne, G. O., Harrold, E., Iqbal, S., Cowzer, D., & Duffy, A. G. (2025). An analysis of compassionate access programmes for novel oncology drugs. Irish journal of medical science, 194(3), 807–815. https://doi.org/10.1007/s11845-025-03930-7
- Keogan, A., Nguyen, T. N. Q., Bouzy, P., Stone, N., Jirstrom, K., Rahman, A., Gallagher, W. M., & Meade, A. D. (2025). Prediction of post-treatment recurrence in early-stage breast cancer using deep-learning with mid-infrared chemical histopathological imaging. NPJ precision oncology, 9(1), 18. https://doi.org/10.1038/s41698-024-00772-x
- Khan, M. R., Kearney Sheehan, P., Bazin, A., Leonard, C., Corrigan, L., & McDermott, R. (2025). Impact of Testicular Cancer on the Socio-Economic Health, Sexual Health, and Fertility of Survivors-A Questionnaire Based Survey. Cancers, 17(11), 1826. https://doi.org/10.3390/cancers17111826
- Khan, M., Sheehan, P. K., Bazin, A., Farooq, A. R., Leonard, C., Aleem, U., Corrigan, L., & McDermott, R. (2025). Long-term side effects of testicular cancer and treatment (observational study of mortality and morbidity in testicular cancer survivors). Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 33(5), 413. https://doi.org/10.1007/s00520-025-09447-0
- Knox, J. J., Jang, G. H., Grant, R. C., Zhang, A., Ma, L., Elimova, E., Jang, R., Moore, M., Biagi, J., Tehfe, M., Ramjeesingh, R., Tsang, E. S., Holter, S., Ramotar, S., Hutchinson, S., Liang, S. B., Lungu, I. M., Moura, S., Wang, Y., Perera, S., … O'Kane, G. M. (2025). Whole genome and transcriptome profiling in advanced pancreatic cancer patients on the COMPASS trial. Nature communications, 16(1), 5919. https://doi.org/10.1038/s41467-025-60808-z
- Krzyzanowska, A., Higgins, D. F., Barron, S., Loughman, T., O'Neill, A., Sheehan, K. M., Wang, C. A., Fender, B., McGuire, L., Fay, J., O'Grady, A., O'Leary, D., Watson, R. W., Bjartell, A., & Gallagher, W. M. (2024). Clinical validation of a biopsy-based six-gene signature prognostic for aggressive prostate cancer. BJUI compass, 6(1), e474. https://doi.org/10.1002/bco2.474
- Leone, G., Orlando, F., Dutey-Magni, P., Vainauskas, O., Grist, E., Ciani, Y., Lall, S., Thakali, S., Wingate, A., Wetterskog, D., Sachdeva, A., Sydes, M. R., McPhail, N., Sreenivasan, T., O'Sullivan, J. M., Clarke, N. W., Parmar, M. K. B., Brown, L. C., James, N. D., Demichelis, F., … STAMPEDE collaborators (2025). Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer: the STAMPEDE Phase 3 Randomized Clinical Trial. JAMA oncology, 11(4), 426–429. Advance online publication. https://doi.org/10.1001/jamaoncol.2024.7051
- Li, M., Devane, D., Beecher, C., Dowling, M., Duffy, A. G., Duggan, C., Grimes, D. R., Kennan, A., Kilty, C., Nsangi, A., Oxman, A. D., Stewart, D. C., Toomey, E., & Tierney, M. (2025). Developing critical thinking and decision-making skills for cancer information: the Informed Health Choice-Cancer online learning resource. Journal of cancer survivorship : research and practice, 10.1007/s11764-025-01874-6. Advance online publication. https://doi.org/10.1007/s11764-025-01874-6
- Li, Z., Aliseda, D., Jones, O., Rajendran, L., Magyar, C., Grant, R., O'Kane, G. M., Saborowski, A., Sapisochin, G., & Vogel, A. (2024). Recent advances in systemic therapy for advanced biliary tract cancer: A systematic review and meta-analysis using reconstructed RCT survival data. JHEP reports : innovation in hepatology, 7(3), 101290. https://doi.org/10.1016/j.jhepr.2024.101290
- Li, Z., Chen, I. C., Centonze, L., Magyar, C. T. J., Choi, W. J., Ivanics, T., O'Kane, G. M., Vogel, A., Erdman, L., De Carlis, L., Lerut, J., Lai, Q., Agopian, V. G., Mehta, N., Chen, C. L., & Sapisochin, G. (2025). Validation of the Toronto recurrence inference using machine-learning for post-transplant hepatocellular carcinoma model. Communications medicine, 5(1), 284. https://doi.org/10.1038/s43856-025-00994-5
- Li, Z., Chen, I. C., Centonze, L., Magyar, C. T. J., Choi, W. J., Shah, S., O'Kane, G. M., Vogel, A., De Carlis, L., Lerut, J., Lai, Q., Mehta, N., Chen, C. L., & Sapisochin, G. (2025). Analysis of treatment benefits and prognostic factors for posttransplant HCC recurrence in a large Euro-American-Asian cohort. Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 31(4), 450–463. https://doi.org/10.1097/LVT.0000000000000501
- Li, Z., Yan, M., Claasen, M. P. A. W., Rajendran, L., Magyar, C. T. J., Saha, S., Lee, C., Selzner, N., Jaeckel, E., Ghanekar, A., Cattral, M., Sayed, B. A., Selzner, M., McGilvray, I., Shwaartz, C., Reichman, T., O'Kane, G. M., Vogel, A., Grant, R. C., Kim, T. K., … Sapisochin, G. (2025). SBRT for bridging and downstaging HCC before transplant. JHEP reports : innovation in hepatology, 7(8), 101451. https://doi.org/10.1016/j.jhepr.2025.101451
- Magyar, C. T. J., O'Kane, G. M., Aceituno, L., Li, Z., Vogel, A., Bruix, J., Mazzaferro, V., & Sapisochin, G. (2025). Liver Transplantation for Hepatocellular Carcinoma: An Expanding Cornerstone of Care in the Era of Immunotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 43(5), 589–604. https://doi.org/10.1200/JCO.24.00857
- Magyar, C. T. J., Perera, S., Rajendran, L., Li, Z., Almugbel, F. A., Feng, S., Choi, W. J., Aceituno, L., Vogel, A., Grant, R. C., Selzner, N., Jaeckel, E., Falla-Rad, N., Knox, J. J., Chen, E. X., Sapisochin, G., & O'Kane, G. M. (2025). Comparative Outcome Analysis of Lenvatinib Versus Sorafenib for Recurrence of Hepatocellular Carcinoma After Liver Transplantation. Transplantation, 109(4), 681–690. https://doi.org/10.1097/TP.0000000000005240
- Magyar, C. T. J., Rajendran, L., Li, Z., Banz, V., Vogel, A., O'Kane, G. M., Chan, A. C., & Sapisochin, G. (2025). Precision surgery for hepatocellular carcinoma. The lancet. Gastroenterology & hepatology, 10(4), 350–368. https://doi.org/10.1016/S2468-1253(24)00434-5
- Maharaj, T., Steele, C., Gyorffy, H., Nicholson, S., Milewski, L., Aird, J. J., Mulsow, J., & Cowzer, D. (2025). Young-onset epithelioid type malignant peritoneal mesothelioma with loss of BAP1 gene expression. BMJ case reports, 18(7), e264825. https://doi.org/10.1136/bcr-2025-264825
- Mahdi, A. F., Ashfield, N., Crown, J., & Collins, D. M. (2025). Pre-Clinical Rationale for Amcenestrant Combinations in HER2+/ER+ Breast Cancer. International journal of molecular sciences, 26(2), 460. https://doi.org/10.3390/ijms26020460
- Mehra, N., Antonarakis, E. S., Park, S. H., Goh, J. C., McDermott, R., Sala Gonzalez, N., Fong, P. C., Greil, R., De Santis, M., Yanez, P. E., Huang, Y. H., Begbie, S. D., Rey, F., Kramer, G., Suzuki, H., Saretsky, T. L., Ghate, S. R., Cui, Y., Hosius, C., & Yu, E. Y. (2025). Patient-reported Outcomes in KEYLYNK-010: Pembrolizumab Plus Olaparib Versus Abiraterone or Enzalutamide for Participants with Biomarker-unselected, Previously Treated Metastatic Castration-resistant Prostate Cancer. European urology oncology, 8(4), 1030–1040. https://doi.org/10.1016/j.euo.2025.04.018
- Myojin, Y., Babaei, S., Trehan, R., Hoffman, C., Kedei, N., Ruf, B., Benmebarek, M. R., Bauer, K. C., Huang, P., Ma, C., Monge, C., Xie, C., Hrones, D., Duffy, A. G., Armstrong, P., Kocheise, L., Desmond, F., Buchalter, J., Galligan, M., Cantwell, C., … Greten, T. F. (2025). Multiomics analysis of immune correlatives in hepatocellular carcinoma patients treated with tremelimumab plus durvalumab. Gut, 74(6), 983–995. https://doi.org/10.1136/gutjnl-2024-334026
- O'Grady, S., Ralston, J. C., McKiernan, E., Drummond, F. J., Rynne, J., Mitchell, D., Bray, I., Gallagher, W. M., Drury, A., & Kolch, W. (2025). Research opportunities in precision oncology: perspectives on biospecimen and genomic data sharing from adults with cancer in Ireland. Irish journal of medical science, 10.1007/s11845-025-04082-4. Advance online publication. https://doi.org/10.1007/s11845-025-04082-4
- O'Grady, S., Ralston, J. C., McKiernan, E., Lanigan, F., Salauddin, M., Sharmin, S., McVeigh, T., Gallagher, W. M., Guerin, S., Rahman, A., & Kolch, W. (2025). Invisible spectrum: a model for minority community public engagement in cancer research. Research involvement and engagement, 11(1), 53. https://doi.org/10.1186/s40900-025-00726-y
- Peccatori, F. A., Niman, S. M., Partridge, A. H., Ruggeri, M., Colleoni, M., Saura, C., Shimizu, C., Satersdal, A. B., Kroep, J. R., Gelmon, K., Amant, F., Mailliez, A., Moore, H. C. F., Ruiz-Borrego, M., Walshe, J. M., Borges, V. F., Gombos, A., Kataoka, A., Rousset-Jablonski, C., Borstnar, S., … International Breast Cancer Study Group and the POSITIVE Trial Collaborators (2025). Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 43(24), 2712–2719. https://doi.org/10.1200/JCO-24-02697
- Petrylak, D. P., Ratta, R., Matsubara, N., Korbenfeld, E., Gafanov, R., Mourey, L., Todenhöfer, T., Gurney, H., Kramer, G., Bergman, A. M., Zalewski, P., De Santis, M., Armstrong, A. J., Gerritsen, W., Pachynski, R., Byun, S. S., Retz, M., Levesque, E., McDermott, R., Bracarda, S., … Fizazi, K. (2025). Pembrolizumab Plus Docetaxel Versus Docetaxel for Previously Treated Metastatic Castration-Resistant Prostate Cancer: The Randomized, Double-Blind, Phase III KEYNOTE-921 Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 43(14), 1638–1649. https://doi.org/10.1200/JCO-24-01283
- Rimassa, L., Lamarca, A., O'Kane, G. M., Edeline, J., McNamara, M. G., Vogel, A., Fassan, M., Forner, A., Kendall, T., Adeva, J., Casadei-Gardini, A., Fornaro, L., Hollebecque, A., Lowery, M. A., Macarulla, T., Malka, D., Mariamidze, E., Niger, M., Ustav, A., Bridgewater, J., … Braconi, C. (2025). Correction to "New systemic treatment paradigms in advanced biliary tract cancer and variations in patient access across Europe" [The Lancet Regional Health - Europe, volume 50, March 2025, 101170]. The Lancet regional health. Europe, 53, 101306. https://doi.org/10.1016/j.lanepe.2025.101306
- Rischin, D., Porceddu, S., Day, F., Brungs, D. P., Christie, H., Jackson, J. E., Stein, B. N., Su, Y. B., Ladwa, R., Adams, G., Bowyer, S. E., Otty, Z., Yamazaki, N., Bossi, P., Challapalli, A., Hauschild, A., Lim, A. M., Patel, V. A., Walker, J. L., De Liz Vassen Schurmann, M., … C-POST Trial Investigators (2025). Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell Carcinoma. The New England journal of medicine, 393(8), 774–785. https://doi.org/10.1056/NEJMoa2502449
- Tang, M., Crown, J., & Duffy, M. J. (2025). Targeting MYC for the treatment of breast cancer: use of the novel MYC-GSPT1 degrader, GT19630. Investigational new drugs, 43(1), 167–179. https://doi.org/10.1007/s10637-024-01504-5
- Van den Hurk, K., Lommen, K., Coussement, L., van den Kerkhof, D., Beckers, M., Trooskens, G., Van Neste, L., Oosterhof, M., van Doorn, R., van den Oord, J. J., Kerkhofs, T., Aarts, M. J. B., Ramaekers, B., Joore, M., Winnepenninckx, V. J. L., Van Criekinge, W., Gallagher, W., De Meyer, T., Smits, K. M., & van Engeland, M. (2025). Comprehensive Analysis of the Melanoma DNA Methylome Identifies LY75 Methylation as an Independent Marker Predicting Poor Clinical Outcome. The Journal of investigative dermatology, S0022-202X(25)02311-5. Advance online publication. https://doi.org/10.1016/j.jid.2025.07.010
- Victory, L., Quigley, C., Doheny, J., Flynn, A., Potter, S., & Moloney, F. J. (2025). Goldfinger: a case of a patient with metal tattooing mimicking recurrent melanoma. Clinical and experimental dermatology, 50(2), 491–493. https://doi.org/10.1093/ced/llae370